Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Maze Therapeutics
AddedFeb 13, 2024
UpdatedJun 18, 2026
Maze Therapeutics

Maze Therapeutics

California-based medical organization innovating therapies through genetic insights.

HQ
South San Francisco, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Maze Therapeutics, founded in South San Francisco, California, is dedicated to translating genetic insights into therapeutic innovations. The company's core mission is to develop breakthrough precision medicines for common diseases with significant unmet medical needs. Leveraging advances in human genetics, variant functionalization, and therapeutic discovery, Maze Therapeutics aims to decode genetic drivers to create new therapies. Their market focus includes serious diseases, with a notable commitment to kidney disease.

Notable affiliated individuals and investors include industry experts and leading venture capital firms. Maze Therapeutics has achieved significant milestones in drug development, particularly in precision medicine. Their innovative approach has positioned them as a key player in the biotech industry, making substantial impacts on therapeutic strategies for complex diseases.

Maze Therapeutics - Similar Companies

Mahzi Therapeutics logo

Mahzi Therapeutics

mahzi.com

Encoded Therapeutics logo

Encoded Therapeutics

Moma Therapeutics logo

Moma Therapeutics

Denali Therapeutics logo

Denali Therapeutics

Mistral Therapeutics logo

Mistral Therapeutics

Neuron23 logo

Neuron23

Faze Medicines logo

Faze Medicines

fazemed.com

Mozarc Medical logo

Mozarc Medical

mozarcmedical.com

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Frontier Medicines logo

Frontier Medicines

frontiermeds.com

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Marlinspike Therapeutics logo

Marlinspike Therapeutics

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

Blade Therapeutics logo

Blade Therapeutics

Maze Therapeutics - Quick Facts

Who are Maze Therapeutics' competitors?

Companies similar to Maze Therapeutics include Mahzi Therapeutics, Encoded Therapeutics, Moma Therapeutics and Denali Therapeutics.

When was Maze Therapeutics founded?

Maze Therapeutics was founded in 2018.

Where is Maze Therapeutics' headquarters located?

Maze Therapeutics' headquarters is located in South San Francisco, CA, US.

When was Maze Therapeutics' last funding round?

Maze Therapeutics' most recent funding round was for $190M (USD) in January 2022.

How much has Maze Therapeutics raised to-date?

As of Jan 10, 2022, Maze Therapeutics has raised a total of $381M (USD).

How many employees does Maze Therapeutics have?

Maze Therapeutics has 135 employees as of Feb 4, 2024.

Maze Therapeutics - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
  • GenAI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Precision Medicines
Unique IDs
  • ein: 000000000
  • secCik: 0001842295
  • ticker: MAZE
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified